Analyst Ratings For Dermira (NASDAQ:DERM)
Today, Dermira (NASDAQ:DERM) stock was downgraded by Mizuho from Buy to Neutral.
Some recent analyst ratings include
- 3/5/2018-Mizuho was Downgraded by analysts at Mizuho from a “Buy ” rating to a ” Neutral” rating.
- 12/14/2017-Guggenheim Reiterated Rating of Buy.
- 11/7/2017-Needham & Company LLC Reiterated Rating of Buy .
- 6/29/2017-Evercore ISI initiated coverage with a Outperform rating.
Recent Insider Trading Activity For Dermira (NASDAQ:DERM)
Dermira (NASDAQ:DERM) has insider ownership of 13.30% and institutional ownership of 94.67%.
- On 3/1/2018 David E Cohen, Director, sold 600 with an average share price of $25.85 per share and the total transaction amounting to $15,510.00.
- On 3/1/2018 Eugene A Bauer, Insider, sold 500 with an average share price of $25.32 per share and the total transaction amounting to $12,660.00.
- On 2/1/2018 David E Cohen, Director, sold 600 with an average share price of $28.87 per share and the total transaction amounting to $17,322.00.
- On 2/1/2018 Eugene A Bauer, Insider, sold 3,000 with an average share price of $28.55 per share and the total transaction amounting to $85,650.00.
- On 1/2/2018 Christopher M Griffith, SVP, sold 18,458 with an average share price of $27.05 per share and the total transaction amounting to $499,288.90.
- On 1/2/2018 David E Cohen, Director, sold 600 with an average share price of $28.03 per share and the total transaction amounting to $16,818.00.
- On 1/2/2018 Eugene A Bauer, Insider, sold 3,000 with an average share price of $27.07 per share and the total transaction amounting to $81,210.00.
Recent Trading Activity for Dermira (NASDAQ:DERM)
Shares of Dermira closed the previous trading session at with 9.420000076293945 shares trading hands.